Tibet Pharmaceutical (600211.SH) announced that the company and its subsidiary Tibet Nordicang Pharmaceutical Co., Ltd. in 2023...
According to the Zhitong Finance App, Tibet Pharmaceutical (600211.SH) announced that the company and its subsidiary Tibet Nodicon Pharmaceutical Co., Ltd. received 53.035 million yuan in industrial support funds from the Shannan Happy Home Construction Administration on December 14, 2023, accounting for 14.34% of the company's net profit attributable to shareholders of listed companies in the most recent period (2022).